PTPN14 and breast ductal adenocarcinoma: In invasive ductal breast carcinomas, the expression of PTPN14 is lower (threefold) in comparison to ductal carcinomas, and the survival of breast cancer patients decreased if the tumors expressed high levels of the PTPN14 substrates, RIN1 or PKC-δ [32].